StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Headlines  
 
  Updates  
 
 
Novavax
3.95
-4.82%
 

NVAX

 

Novavax

$ 3.95

 
-$0.20 | -4.82%
 
 
Open
$ 4.09
 
 
MKT CAP
$ 552.81M
 
High
$ 4.12
 
 
VOL
$ 3.34M
 
Low
$ 3.90
 
 
AVG VOL
$ 4.08M
 
 
 

NVAX Stock Analysis

  Login to display Novavax (NVAX) recommendation from the last 90 days from financial news and social media.
 
 

NVAX Total Score

 
 

Strengths

NVAX Rewards

 Earnings are forecast to grow

 
 

Chart

 
 

4.98

4.19

5.36

7.67

 
 
1month
3month
6month
1year
 
Total Return
NVAX
vs.
S&P500
 

 
1-week Return
-0.50%
 
+1.63%
 
 
5-week Return
-16.31%
 
-3.68%
 
 
10-week Return
-1.99%
 
+0.43%
 
 
 

NVAX Risk Level

This Indicator assigning NVAX risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
NVAX Risk Level
LOW
HIGH

Risk Volatility

 

NVAX has High Risk Level

Click here to check what is your level of risk

 

NVAX Analysts Opinion

NVAX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

2.00
 

NVAX Earnings Sentiment

 Below analyst estimate

NVAX Earnings Sentiment

 Reported a weak earnings

NVAX Earnings Sentiment

 Has a weak balance sheet

 
 

Rating

×
 

Rating

2.00
 
 

Momentum

×
 

Momentum

2.00
 

NVAX Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

3.40
 
 

Future

×
 

Future

4.00
 

NVAX Future Sentiment

 Earnings are forecast to grow

 
 

NVAX Analysts Opinion

NVAX Analysts opinion is negative but has improved from the past 3 months

 

NVAX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
65%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
0%
0%
100%
 
On Track
On Track
On Track
 

NVAX Street Opinion 

NVAX Street view is bullish and have positive views on the near-term outlook

 

NVAX Performance Sentiment

Sentiments overview associated with NVAX events and the stock performance.
 
65%
35%
Positive
Negative
11 out of 17
events present
6 out of 17
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

NVAX Earnings

The TTM reflects 12-month period, providing review of NVAX financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
974
1,982
1,146
-7.81%
 
 
Cost of Revenue
371
903
-
 
 
Gross Profit
603
1,079
1,146
-27.46%
 
 
Operating Exp
1,230
1,724
2,833
-34.11%
 
 
Operating Inc
-627
-645
-1,687
-
 
 
Net Interest Inc
-15
-20
-21
-
 
 
Interest Exp
15
20
21
-15.48%
 
 
Other Income
91
11
-7
-
 
 
EPS
-6.23
-8.42
-23.44
-
 
 
Next Earnings Date: May 02, 2024
 
 
Linked to NVAX
Total Score
Close Price
% Change

 

MRNA

Moderna

3.16

106.18

-2.45%

 
 
 
Headlines
Last Modify
Price
% Change

 
HR Activity
1 Week Ago
4.12
-3.74%
 
Weak Earnings
1 Week Ago
4.30
+0.94%
 
 
NVAX Latest News +
 
 
StocksRunner

Explore our NVAX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored NVAX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our NVAX Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
 

Recently Viewed

 

NVAX

Novavax

 
 
 

Most Trending

 
 
 
 

-8.25%

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

NVAX Rewards

 Earnings are forecast to grow

 
 
 

NVAX Risk Level

 
 
 

The Indicator assigning NVAX risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
NVAX Risk Level
LOW
HIGH

Risk Volatility

 

NVAX has High Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

NVAX

 

Novavax

$ 3.95

 
-$0.20 | -4.82%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Headlines  
 
  Updates  
 

 
joker
 
 
 
Open
$ 4.09
 
 
MKT CAP
$ 552.81M
 
High
$ 4.12
 
 
VOL
$ 3.34M
 
Low
$ 3.90
 
 
AVG VOL
$ 4.08M
 
 
 

NVAX Analysis

  Sign in to view Novavax (NVAX) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

4.98

4.19

5.36

7.67

 
 
1month
3month
6month
1year
 
Total Return
NVAX
vs.
S&P500
 

 
1-week Return
-0.50%
 
+1.63%
 
 
5-week Return
-16.31%
 
-3.68%
 
 
10-week Return
-1.99%
 
+0.43%
 
 
 

NVAX Analysts Opinion

NVAX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

2.00
 

NVAX Earnings Sentiment

 Below analyst estimate

NVAX Earnings Sentiment

 Reported a weak earnings

NVAX Earnings Sentiment

 Has a weak balance sheet

 
 

Rating

×
 

Rating

2.00
 
 

Momentum

×
 

Momentum

2.00
 

NVAX Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

3.40
 
 

Future

×
 

Future

4.00
 

NVAX Future Sentiment

 Earnings are forecast to grow

 
 

NVAX Analysts Opinion

NVAX Analysts opinion is negative but has improved from the past 3 months

 

NVAX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
65%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
0%
0%
100%
 
On Track
On Track
On Track
 

NVAX Street Opinion 

NVAX Street view is bullish and have positive views on the near-term outlook

 
NVAX Performance Sentiment
Sentiments overview associated with NVAX events and the stock performance.
 
65%
35%
Positive
Negative
11 out of 17
events present
6 out of 17
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

NVAX Earnings

The TTM data reflects the most recent 12-month period, providing overview of NVAX financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
974
1,982
1,146
-7.81%
 
 
Cost of Revenue
371
903
-
 
 
Gross Profit
603
1,079
1,146
-27.46%
 
 
Operating Exp
1,230
1,724
2,833
-34.11%
 
 
Operating Inc
-627
-645
-1,687
-
 
 
Net Interest Inc
-15
-20
-21
-
 
 
Interest Exp
15
20
21
-15.48%
 
 
Other Income
91
11
-7
-
 
 
EPS
-6.23
-8.42
-23.44
-
 
 
Next Earnings Date: May 02, 2024
 
Headlines
Last Modify
Price
% Change

 
HR Activity
1 Week Ago
4.12
-3.74%
 
Weak Earnings
1 Week Ago
4.30
+0.94%
 
 
NVAX Latest News +
 
 
 
 
 

Score Tracker

 
 
 
Based on 17 events in the last 90 days from financial news and social media. Last updated Apr 25, 2024 21:04 Wall St. time
 
 

NVAX Total Score

 
 
 
 
 

Linked to NVAX

 
 
 
Symbol
Score
% Change
 

MRNA

Moderna

3.16

-2.45%

106.18

 
 
 
 
 
 
StocksRunner

Discover NVAX Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of NVAX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our NVAX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVAX Stock trends

NVAX Stock performance

NVAX Stock analysis

NVAX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker